Richard Giltner - 16 Nov 2022 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role: Director
Signature: /s/ John S. Hess, under Power of Attorney
Issuer symbol: UTHR
Transactions as of: 16 Nov 2022
Net transactions value: -$1,971,500
Form type: 4
Filing time: 17 Nov 2022, 15:30:33 UTC
Previous filing: 08 Jul 2022
Next filing: 23 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	UTHR	Common Stock	Options Exercise	$639,000	+10,000	+72%	$63.90	23,870	16 Nov 2022	Direct	F1
transaction	UTHR	Common Stock	Disposed to Issuer	$2,610,500	-10,000	-42%	$261.05	13,870	16 Nov 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	UTHR	Share Tracking Award	Options Exercise	$0	-10,000	-67%	$0.000000	5,000	16 Nov 2022	Common Stock	10,000	$63.90	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. These particular share tracking awards were approaching the end of their 10-year term on June 26, 2023.
F2	Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.